Our Offerings

Our cGMP-compliant cell bank can preserve a large volume of cell lines, microbial cells, and other biologics for the manufacture of commercially available therapeutics.

We ensure that all samples collected either on the field or on our biobank are carefully processed and transported using the best techniques for preservation.

We take part on several preclinical to clinical testing to determine efficacy of medical drugs and substances.

Our dedicated scientist can serve as your partner from lead optimization to commercialization for your next advanced therapy.

Apart from process equipment and turnkey facilities, we offer process development to support client's specific needs and requirements for cell culture process development and optimization. This includes cell culture medium optimization, seed preparation process development, and system layout and process integration.

We are able to provide fast, efficient and robust vaccine technology transfer with single-use solutions, predictive process control, process scale up/scale down, complexity reduction, and process validation.

We provide clients with end to end contract development and manufacturing services for food ingredient and food product.

We offer CDMO services to manufacture various grades of plasmid DNA for preclinical, clinical and commercial production. We maintain GMP standards from the starting material to the final drug products in our Plasmid DNA production process.

Extracellular vesicles are secreted by many cells, of which the common ones are Mesenchymal Stromal Cells, Pericytes, CAR-T cells, human primary bronchial epithelial cell, epithelial cells, EBV(Epstein-Barr virus)-immortalized B cells, HUVECs (Human umbilical vein endothelial cells) Leukocytes, platelets, cancer cells and even neural cells. They are classified into three groups depending on their size.

We specialize and are best-in-class in accelerated adherent cell line creation and development in conjunction with our adherent cell banking, characterization, testing and storage services for your various applications.

At Esco Aster, we leverage our expertise into the production of genetically-modified cell therapy such as CAR-Immune cells (T cells, NK cells, Dendritic cells). Our adaptable and dynamic approaches employed across multiple cell types coupled with cancer experts enable us to provide process design and developmental solutions all the way through GMP manufacture and supply.